Danny Burke, CEO at Ecancer, shared a post on LinkedIn:
“Need to find out more about advanced acral melanoma in Peru? We’ve recently published a study exploring clinicopathological traits, treatment response and BRAF status in affected patients.
This further underlines our Journal’s commitment to increase research capacity in under-supported parts of the world.”
Title: Clinicopathological features, response patterns, outcomes for and BRAF status in patients with advanced acral melanoma: a preliminary Peruvian study
Journal: ecancermedicalscience
Authors: Denisse Castro, Brady Beltrán, Oscar Carnero, Mauricio Póstigo, Wilhelm Valdivia, Cinthia Figueroa, Manuel Leiva, Marco López, Virgilio E Failoc-Rojas
Read More Article.
More posts featuring Danny Burke on OncoDaily.